26 results
Running out of Analgesia and Sedation Medications due to #COVID19?  Anand Swaminathan, MD has put
due to #COVID19 ... #management ... #covid19 #treatment ... #sarscov2 #criticalcare ... sedative #analgesia #pharmacology
Brief Overview of Treatment Agents for COVID-19 - Version 2.01 4/11/2020

#Drugs #Medications #Treatment #COVID19 #Pharmacology #Table
Agents for COVID ... 2020 #Drugs #Medications ... #Treatment #COVID19 ... #Pharmacology # ... Table #Management
Drugs Used for the Treatment of COVID-19 Infection
LOPINAVIR / RITONAVIR
INTERFERON Beta-I
REMDESIVIR
HYDROXYCHLOROQUINE
TOCILIZUMAB

Piotr Okupski @PiotrOkupski - Original Infographic
of COVID-19 Infection ... smfarmhosp_smfh #Drugs #Medications ... #Treatment #COVID19 ... #Pharmacology # ... Table #Management
IDSA Treatment of Necrotizing Infections of the Skin, Fascia, and Muscle
 • Mixed infections
 • Streptococcus
IDSA Treatment of ... fasciitis #Skin #IDSA ... #Treatment #management ... #antibiotics #pharmacology
Parenteral Antimicrobial Treatment of Common Microorganisms Causing Native Vertebral Osteomyelitis - IDSA 
Staphylococci, oxacillin susceptible
Staphylococci, oxacillin
Antimicrobial Treatment ... Parenteral #IV #Antibiotics ... Osteomyelitis #management ... #treatment #pharmacology ... #idsa
Immediate Treatment for Myocardial infraction
#management #pharmacology #medications #treatment #cardiology #mnemonic
Immediate Treatment ... Myocardial infraction #management ... #pharmacology # ... medications #treatment ... #cardiology #mnemonic
COVID-19 review…here is a list of some of the drugs that are currently being used or
most effective treatments ... #CoronaVirus #Treatment ... #Management #Pandemic ... Pharmacotherapy #Pharmacology ... #CriticalCare #
Ivermectin. Old anti-parasitic agent making a comeback with recent headlines from in-vitro study that showed antiviral
virus causing COVID ... InfectiousDiseases #CriticalCare ... EmergencyMedicine #Pharmacology ... #Treatment #Virus ... #Antiviral #Management
Outpatient Treatment of with Community-Acquired Pneumonia (CAP)
No comorbidities or risk factors for MRSA or Pseudomonas aeruginosa:
Outpatient Treatment ... fluoroquinolone #IDSA ... Acquired #Pneumonia #Antibiotics ... #Management #Guidelines ... #pharmacology
High yield pharmacology notes
#pharmacology #cardiology #management #medications #criticalcare #treatment
High yield pharmacology ... notes #pharmacology ... #cardiology #management ... #medications #criticalcare ... #treatment